Acquisition adds a potential first-in-class in vivo targeted lipid nanoparticle (tLNP) anti-CD19 CAR-T therapy candidate for B cell-mediated autoimmune diseases as well as a proprietary tLNP platform designed to deliver RNA… Read More
VANCOUVER, BC – Acuitas Therapeutics announced the publication of a new study in Science Translational Medicine, titled “Nonstabilized SARS-CoV-2 spike mRNA vaccination induces broadly neutralizing antibodies in nonhuman primates.” The… Read More
The Terry Fox Research Institute is pleased to welcome four new members to its Board of Directors. Their expertise and insight will help guide TFRI as we continue to invest… Read More
RESEARCH TRIANGLE PARK, NC and PLEASANTON, CA — IQVIA (NYSE: IQV) and Veeva Systems (NYSE: VEEV) announced global clinical and commercial partnerships and the complete resolution of all pending legal disputes. Under… Read More
Partnership brings ViewsML’s virtual IHC platform to iProcess customers – enabling faster, tissue-sparing biomarker testing We’re excited to partner with iProcess to bring the benefits of our virtual IHC platform… Read More
